Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 3 2Phase 2 2

Status

Completed 3Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 8OTHER_GOV 1NETWORK 1

Study Type

Interventional 8Observational 2Expanded_access 1

Sponsor

Cancer Type

Dermatologic 3Tumor-Agnostic 1Gastrointestinal 1Breast 1

Conditions

Melanoma 3Warts 1Recurrence 1Neoplasms 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Condylomata Acuminata 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
OTHER × Interventional × Vaccination × Clear all
NCT04335890 2026-03-04

IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

Hasumi International Research Foundation

Phase 1 Completed
17 enrolled
Dermatologic

Melanoma

NCT04814446 2025-01-23

VAC-WARTS

Assistance Publique - Hôpitaux de Paris

Phase 3 Recruiting
146 enrolled

Warts

NCT01390064 2019-08-20

Vaccination of High Risk Breast Cancer Patients

University of Arkansas

Phase 1 Completed
6 enrolled 7 charts
Breast

Breast Neoplasms

NCT01342224 2018-04-12

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Providence Health & Services

Phase 1 Completed
11 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT03296397 2018-02-27

CONDYVAC

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
300 enrolled

Condylomata Acuminata, Recurrence

NCT01042366 2017-08-16

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

University of Pittsburgh

Phase 2 Terminated
16 enrolled 8 charts
Dermatologic

Melanoma

NCT01216436 2015-05-25

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Duke University

Phase 1 Terminated
2 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT01267578 2010-12-28

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

University of Yamanashi

Phase 2 Unknown
60 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡